These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21653957)

  • 1. Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa.
    Bishai DM; Champion C; Steele ME; Thompson L
    Health Aff (Millwood); 2011 Jun; 30(6):1058-64. PubMed ID: 21653957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.
    LaForce FM; Okwo-Bele JM
    Health Aff (Millwood); 2011 Jun; 30(6):1049-57. PubMed ID: 21653956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the Meningitis Vaccine Project.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Viral Immunol; 2018 Mar; 31(2):109-113. PubMed ID: 29116892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
    Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningitis control in countries of the African meningitis belt, 2015.
    Wkly Epidemiol Rec; 2016 Apr; 91(16):209-16. PubMed ID: 27108455
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.
    Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM
    Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
    Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
    Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac
    Kulkarni PS; Jadhav SS; LaForce FM
    Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
    Miller MA; Wenger J; Rosenstein N; Perkins B
    Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.
    Okwo-Bele JM; LaForce FM; Borrow R; Preziosi MP
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S389-90. PubMed ID: 26553664
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningitis epidemics in Africa: a brief overview.
    Teyssou R; Muros-Le Rouzic E
    Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.